Literature DB >> 11814618

1A-779 attenuates angiotensin-(1-7) depressor response in salt-induced hypertensive rats.

Mohamed A Bayorh1, Danita Eatman, Marcus Walton, Robin R Socci, Myrtle Thierry-Palmer, Nerimiah Emmett.   

Abstract

Chronic infusion of angiotensin-(1-7) [Ang-(1-7)] lowers blood pressure in salt-induced and spontaneously hypertensive (SHR) rats. In the present study, we have examined the acute effect of Ang-(1-7) in salt-induced hypertension using Dahl salt-sensitive rats placed on low (0.3%) or high (8.0% NaCl) salt diets for 2 weeks. Rats fed a high salt diet showed a greater rise in BP than those fed a low salt diet. Ang-(1-7) (24 microg/kg) reduced mean arterial pressure (MAP), enhanced the release of prostacyclin and nitric oxide, and suppressed thromboxane A(2) levels. A-779 (48 microg/kg, i.v), a selective Ang-(1-7) antagonist, partially blocked these effects of Ang-(1-7). The Ang-(1-7)-induced depressor response observed in these animals was related to an increase in vasodilatory prostanoids, a decrease in the constrictor prostanoid thromboxane A(2), and an increase in nitric oxide levels in both plasma and isolated aortic rings.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11814618     DOI: 10.1016/s0196-9781(01)00579-4

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  7 in total

Review 1.  Angiotensin-(1-7) as an antihypertensive, antifibrotic target.

Authors:  Michael J Katovich; Justin L Grobe; Mohan K Raizada
Journal:  Curr Hypertens Rep       Date:  2008-06       Impact factor: 5.369

2.  The role of bradykinin, AT2 and angiotensin 1-7 receptors in the EDRF-dependent vasodilator effect of angiotensin II on the isolated mesenteric vascular bed of the rat.

Authors:  R Soares de Moura; A C Resende; A F Emiliano; T Tano; A C Mendes-Ribeiro; M L G Correia; L C R Marins de Carvalho
Journal:  Br J Pharmacol       Date:  2004-02-02       Impact factor: 8.739

Review 3.  Sexual dimorphism in rodent models of hypertension and atherosclerosis.

Authors:  Kristen J Bubb; Rayomand S Khambata; Amrita Ahluwalia
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

4.  Angiotensin II Type 2 Receptor and Receptor Mas Are Colocalized and Functionally Interdependent in Obese Zucker Rat Kidney.

Authors:  Sanket N Patel; Quaisar Ali; Preethi Samuel; Ulrike Muscha Steckelings; Tahir Hussain
Journal:  Hypertension       Date:  2017-08-21       Impact factor: 9.897

5.  New cardiovascular and pulmonary therapeutic strategies based on the Angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor axis.

Authors:  Anderson J Ferreira; Tatiane M Murça; Rodrigo A Fraga-Silva; Carlos Henrique Castro; Mohan K Raizada; Robson A S Santos
Journal:  Int J Hypertens       Date:  2012-01-26       Impact factor: 2.420

Review 6.  Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets.

Authors:  Fan Jiang; Jianmin Yang; Yongtao Zhang; Mei Dong; Shuangxi Wang; Qunye Zhang; Fang Fang Liu; Kai Zhang; Cheng Zhang
Journal:  Nat Rev Cardiol       Date:  2014-04-29       Impact factor: 49.421

7.  Synergism between Angiotensin receptors ligands: Role of Angiotensin-(1-7) in modulating AT2 R agonist response on nitric oxide in kidney cells.

Authors:  Sanket Patel; Tahir Hussain
Journal:  Pharmacol Res Perspect       Date:  2020-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.